Patent ID: 9125970
Filing Date: 2015-09-08
Classification: A61K,A61L,A61P

Abstract:
1. A method of producing a drug delivery device comprising: a) providing a pharmaceutical formulation comprising (i) a volatile solvent, (ii) N-tolyglycine glycidyl methacrylate, also known as, N-tolylglycine glycidyl methacrylate, (iii) bisphenyldimethacrylate, and (iv) a therapeutic agent; b) applying a first layer of the pharmaceutical formulation to a surface of an implantable body of the drug delivery device, wherein the N-tolyglycine glycidyl methacrylate, also known as, N-tolylglycine glycidyl methacrylate and the bisphenyldimethacrylate polymerize to form a first layer of polymerization product; and c) applying a second layer of the pharmaceutical formulation to the first layer of polymerization product, wherein the N-tolyglycine glycidyl methacrylate, also known as, N-tolylglycine glycidyl methacrylate and the bisphenyldimethacrylate of the pharmaceutical composition polymerize to form a second layer of polymerization product.